OBJECTIVE: Although cholinergic deficiency is presumed to increase delirium risk and use of medication with anticholinergic properties in the ICU is frequent, the relationship between anticholinergic medication use and delirium in this setting remains unclear. We investigated whether exposure to medication with anticholinergic properties increases the probability of transitioning to delirium in critically ill adults and whether this relationship is affected by age or the presence of acute systemic inflammation. DESIGN: Prospective cohort study. SETTING: A 32-bed medical-surgical ICU at an academic medical center. PATIENTS: Critically ill adults admitted to the ICU for more than 24 hours without an acute neurological disorder or another condition that would hamper delirium assessment. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Daily anticholinergic burden was calculated for each patient based on the sum of the Anticholinergic Drug Scale score for each medication administered. Daily mental status was classified as "coma," "delirium," or an "awake without delirium" state. The primary outcome, the daily transition from an "awake without delirium" state to "delirium," was analyzed using a first-order Markov model that adjusted for eight covariables. A total of 1,112 patients were evaluated over 9,867 ICU days. The daily median summed Anticholinergic Drug Scale score was 2 (interquartile range, 1-3). The transition from being in an "awake without delirium" state to "delirium" occurred on 562 of ICU days (6%). After correcting for confounding, a one-unit increase in the Anticholinergic Drug Scale score resulted in a nonsignificant increase in the probability of delirium occurring the next day (odds ratio, 1.05; 95% CI, 0.99-1.10). Neither age nor the presence of acute systemic inflammation modified this relationship. CONCLUSIONS: Exposure to medication with anticholinergic properties, as defined by the Anticholinergic Drug Scale, does not increase the probability of delirium onset in patients who are awake and not delirious in the ICU.
OBJECTIVE: Although cholinergic deficiency is presumed to increase delirium risk and use of medication with anticholinergic properties in the ICU is frequent, the relationship between anticholinergic medication use and delirium in this setting remains unclear. We investigated whether exposure to medication with anticholinergic properties increases the probability of transitioning to delirium in critically ill adults and whether this relationship is affected by age or the presence of acute systemic inflammation. DESIGN: Prospective cohort study. SETTING: A 32-bed medical-surgical ICU at an academic medical center. PATIENTS: Critically ill adults admitted to the ICU for more than 24 hours without an acute neurological disorder or another condition that would hamper delirium assessment. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Daily anticholinergic burden was calculated for each patient based on the sum of the Anticholinergic Drug Scale score for each medication administered. Daily mental status was classified as "coma," "delirium," or an "awake without delirium" state. The primary outcome, the daily transition from an "awake without delirium" state to "delirium," was analyzed using a first-order Markov model that adjusted for eight covariables. A total of 1,112 patients were evaluated over 9,867 ICU days. The daily median summed Anticholinergic Drug Scale score was 2 (interquartile range, 1-3). The transition from being in an "awake without delirium" state to "delirium" occurred on 562 of ICU days (6%). After correcting for confounding, a one-unit increase in the Anticholinergic Drug Scale score resulted in a nonsignificant increase in the probability of delirium occurring the next day (odds ratio, 1.05; 95% CI, 0.99-1.10). Neither age nor the presence of acute systemic inflammation modified this relationship. CONCLUSIONS: Exposure to medication with anticholinergic properties, as defined by the Anticholinergic Drug Scale, does not increase the probability of delirium onset in patients who are awake and not delirious in the ICU.
Authors: Matthew S Duprey; John W Devlin; Becky A Briesacher; Thomas G Travison; John L Griffith; Sharon K Inouye Journal: J Am Geriatr Soc Date: 2020-10-01 Impact factor: 5.562
Authors: Matthew S Duprey; Sandra M A Dijkstra-Kersten; Irene J Zaal; Becky A Briesacher; Jane S Saczynski; John L Griffith; John W Devlin; Arjen J C Slooter Journal: Am J Respir Crit Care Med Date: 2021-09-01 Impact factor: 30.528
Authors: Matthew S Duprey; John W Devlin; Johannes G van der Hoeven; Peter Pickkers; Becky A Briesacher; Jane S Saczynski; John L Griffith; Mark van den Boogaard Journal: Crit Care Med Date: 2021-08-01 Impact factor: 9.296
Authors: Angelique Egberts; Saskia T van der Craats; Melissa D van Wijk; Shams Alkilabe; Patricia M L A van den Bemt; Francesco U S Mattace-Raso Journal: Pharmacol Res Perspect Date: 2017-05-11
Authors: Lisa Burry; Damon Scales; David Williamson; Jennifer Foster; Sangeeta Mehta; Melanie Guenette; Eddy Fan; Michael Detsky; Azar Azad; Francis Bernard; Louise Rose Journal: BMJ Open Date: 2017-03-30 Impact factor: 2.692